Syndax to Announce Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 3, 2025
Syndax (Nasdaq: SNDX) will report third quarter 2025 financial results and provide a business update on Monday, November 3, 2025. Management will host a conference call and live audio webcast at 4:30 p.m. ET the same day.
Investors can access the live webcast and slides via the Investors & Events page on the company website or join by phone using Conference ID: Syndax3Q25 (Domestic: 800-590-8290; International: 240-690-8800). A replay will be available on the Investors site about 24 hours after the call and remain accessible for 90 days.
Syndax (Nasdaq: SNDX) riferirà i risultati finanziari del terzo trimestre 2025 e fornirà un aggiornamento sull'attività il lunedì 3 novembre 2025. La direzione terrà una teleconferenza e webcast audio in diretta alle 16:30 ora ET lo stesso giorno.
Gli investitori possono accedere al webcast in diretta e alle slide nella pagina Investitori e Eventi sul sito dell'azienda o partecipare telefonicamente utilizzando l'ID conferenza: Syndax3Q25 (Italia/domestico: 800-590-8290; Internazionale: 240-690-8800). Una replica sarà disponibile sul sito degli Investitori circa 24 ore dopo la chiamata e resterà accessibile per 90 giorni.
Syndax (Nasdaq: SNDX) informará los resultados financieros del tercer trimestre de 2025 y proporcionará una actualización comercial el lunes 3 de noviembre de 2025. La dirección celebrará una llamada de conferencia y webcast de audio en vivo a las 4:30 p.m. ET del mismo día.
Los inversionistas pueden acceder al webcast en vivo y a las diapositivas a través de la página de Inversores y Eventos en el sitio web de la empresa o participar por teléfono utilizando el ID de conferencia: Syndax3Q25 (Nacional: 800-590-8290; Internacional: 240-690-8800). Una repetición estará disponible en el sitio de Inversores aproximadamente 24 horas después de la llamada y permanecerá accesible durante 90 días.
Syndax (나스닥: SNDX)는 2025년 3분기 재무 실적을 발표하고 2025년 11월 3일 월요일에 비즈니스 업데이트를 제공합니다. 경영진은 같은 날 미국 동부 표준시 오후 4시 30분에 컨퍼런스 콜 및 실시간 오디오 webcast를 주최합니다.
투자자들은 회사 웹사이트의 Investors & Events 페이지에서 라이브 webcast와 프레젠테이션을 이용하거나, 전화로 Conference ID Syndax3Q25를 사용하여 참여할 수 있습니다(국내: 800-590-8290; 국제: 240-690-8800). 콜 이후 약 24시간 내에 재방송이 Investors 사이트에 올라오며 90일 동안 접근 가능합니다.
Syndax (Nasdaq : SNDX) publiera les résultats financiers du troisième trimestre 2025 et fournira une mise à jour commerciale le lundi 3 novembre 2025. La direction animera une conférence téléphonique et un webcast audio en direct à 18 h 30, heure de l'Est le même jour.
Les investisseurs peuvent accéder au webcast en direct et aux diapositives via la page Investisseurs & Événements sur le site de l'entreprise ou participer par téléphone en utilisant l'ID de conférence : Syndax3Q25 (national : 800-590-8290; international : 240-690-8800). Une rediffusion sera disponible sur le site des Investisseurs environ 24 heures après l'appel et restera accessible pendant 90 jours.
Syndax (Nasdaq: SNDX) wird die Finanzergebnisse des dritten Quartals 2025 berichten und ein Geschäftsupdate am Montag, 3. November 2025 geben. Das Management wird an diesem Tag eine Telefonkonferenz und Live-Audio-Webcast um 16:30 Uhr ET abhalten.
Investoren können den Live-Webcast und die Folien über die Seite Investorensowie Events auf der Unternehmenswebsite aufrufen oder telefonisch teilnehmen mit der Conference ID: Syndax3Q25 (Inlandsanruf: 800-590-8290; International: 240-690-8800). Eine Wiederholung wird etwa 24 Stunden nach dem Anruf auf der Investorenseite verfügbar sein und für 90 Tage zugänglich bleiben.
Syndax (ناسداك: SNDX) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 وتقدم تحديثًا تجاريًا في الإثنين 3 نوفمبر 2025. ستستضيف الإدارة مكالمة مؤتمرات وبث مباشر صوتي في 4:30 م بتوقيت شرق الولايات المتحدة في اليوم نفسه.
يمكن للمستثمرين الوصول إلى البث المباشر والشرائح عبر صفحة المستثمرين والفعاليات على موقع الشركة أو الانضمام عبر الهاتف باستخدام معرف المؤتمر: Syndax3Q25 (محلي: 800-590-8290; دولي: 240-690-8800). سيكون هناك إعادة بث متاحة على موقع المستثمرين نحو 24 ساعة بعد المكالمة وتظل متاحة لمدة 90 يوماً.
Syndax (纳斯达克: SNDX) 将在2025年第三季度财报公布并在2025年11月3日 星期一提供业务更新。管理层将在同一天的美东时间下午4:30举行电话会议和实时音频网络广播。
投资者可以通过公司网站的 投资者与活动页面访问实时网络广播和幻灯片，或使用会议 ID Syndax3Q25 拨打电话参与（国内：800-590-8290；国际：240-690-8800）。此次电话会约在通话结束后大约 24 小时在投资者网站上提供回放，回放将持续可访问 90 天。
- None.
- None.
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its third quarter 2025 financial results and provide a business update on Monday, November 3, 2025.
In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Monday, November 3, 2025.
The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the following:
Conference ID: Syndax3Q25
Domestic Dial-in Number: 800-590-8290
International Dial-in Number: 240-690-8800
Live webcast: https://sndx-3q25.open-exchange.net
For those unable to participate in the conference call or webcast, a replay will be available on the Investors section of the Company's website at www.syndax.com approximately 24 hours after the conference call and will be available for 90 days following the call.
About Syndax
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.
Syndax Contact
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827
SNDX-G
FAQ
When will Syndax (SNDX) report third quarter 2025 results?
What time is the Syndax (SNDX) earnings call on November 3, 2025?
How can I access the Syndax (SNDX) November 3, 2025 webcast and slides?
What is the Syndax (SNDX) conference call dial-in and conference ID for Q3 2025?
Will there be a replay of the Syndax (SNDX) Q3 2025 earnings call?
Where is the Syndax (SNDX) live webcast link for the November 3, 2025 call?
